Next Article in Journal
Grafting of Amine End-Functionalized Side-Chain Polybenzimidazole Acid–Base Membrane with Enhanced Phosphoric Acid Retention Ability for High-Temperature Proton Exchange Membrane Fuel Cells
Next Article in Special Issue
Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease
Previous Article in Journal
Novichok Nerve Agents as Inhibitors of Acetylcholinesterase—In Silico Study of Their Non-Covalent Binding Affinity
Previous Article in Special Issue
Spinetoram-Induced Potential Neurotoxicity through Autophagy Mediated by Mitochondrial Damage
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 29
Issue 2
10.3390/molecules29020339
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Impact of Preparative Isolation of C-Glycosylflavones Derived from Dianthus superbus on In Vitro Glucose Metabolism

by
Zikai Lin
1,†,
Xiaowei Zhou
1,†,
Chen Yuan
1,2,
Yan Fang
1,2,
Haozheng Zhou
1,
Zhenhua Wang
1,
Jun Dang
2,* and
Gang Li
1,*
1
Center for Mitochondria and Healthy Aging, College of Life Sciences, Yantai University, Yantai 264003, China
2
Qinghai Provincial Key Laboratory of Tibetan Medicine Research, Key Laboratory of Tibetan Medicine Research, Chinese Academy of Sciences, Northwest Institute of Plateau Biology, Xining 810001, China
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Molecules 2024, 29(2), 339; https://doi.org/10.3390/molecules29020339
Submission received: 4 December 2023 / Revised: 4 January 2024 / Accepted: 7 January 2024 / Published: 9 January 2024
(This article belongs to the Special Issue Recent Advances in the Research of Natural Products: Isolation, Identification, Physicochemical Properties and Bioactivities)
Browse Figures
Review Reports Versions Notes

Abstract

:
Dianthus superbus L. has been extensively studied for its potential medicinal properties in traditional Chinese medicine and is often consumed as a tea by traditional folk. It has the potential to be exploited in the treatment of inflammation, immunological disorders, and diabetic nephropathy. Based on previous studies, this study continued the separation of another subfraction of Dianthus superbus and established reversed-phase/reversed-phase and reversed-phase/hydrophilic (RPLC) two-dimensional (2D) high-performance liquid chromatography (HPLC) modes, quickly separating two C-glycosylflavones, among which 2″-O-rhamnosyllutonarin was a new compound and isomer with 6‴-O-rhamnosyllutonarin. This is the first study to investigate the effects of 2″-O-rhamnosyllutonarin and 6‴-O-rhamnosyllutonarin on cellular glucose metabolism in vitro. First, molecular docking was used to examine the effects of 2″-O-rhamnosyllutonarin and 6″-O-rhamnosyllutonarin on AKT and AMPK; these two compounds exhibited relatively high activity. Following this, based on the HepG2 cell model of insulin resistance, it was proved that both of the 2″-O-rhamnosyllutonarin and 6‴-O-rhamnosyllutonarin demonstrated substantial efficacy in ameliorating insulin resistance and were found to be non-toxic. Simultaneously, it is expected that the methods developed in this study will provide a basis for future studies concerning the separation and pharmacological effects of C-glycosyl flavonoids.

1. Introduction

Diabetes has emerged as a rapidly rising global health issue in the 21st century [1,2]. Type II diabetes mellitus (T2DM), representing approximately 85 to 90% of the total population, has increased in prevalence from 4.5% in 1990 to 8.5% from 2016 to 2017 and is projected to rise further by 2030 [3]. Insulin resistance (IR) and dysfunction of pancreatic β-cells are factors that contribute to the progression of T2DM [4,5]. Patients with T2DM may secrete a small amount of insulin by themselves; therefore, hypoglycemic medicines are frequently used to induce insulin secretion from pancreatic β-cells and ameliorate the resistance of effector cells to insulin. It is crucial to identify natural substances that can regulate blood glucose without causing prominent side effects for T2DM treatment [6,7].
Dianthus superbus L. (D. superbus) is a medicinal drug derived from the dried aerial section of the perennial herb Dianthus superbus or Dianthus chinensis. Its primary production is predominantly concentrated in the regions of Shandong, Hebei, and Henan. D. superbus was first reported in the Shennong Classic of Materia Medica and was commonly used by ancient physicians in combination with different Chinese herbs to treat diseases such as heat stranguria, bloody stranguria, etc. [8,9]. Current studies have revealed that D. superbus mainly consists of anthocyanin, methyl salicylate, eugenol, vitamin A, saponins, and flavonoids that exhibit pharmacological properties including diuretic, antioxidant, hypotensive, and anti-neuritic effects. Most of the studies concerning D. superbus are confined to its chemical constituents, however, limited research explores its biological impacts and mechanisms.
Column chromatography and silica gel chromatography are traditional methods used for the extraction and purification of natural product compounds. However, both methods are afflicted with low resolution, weak separation operations, and insufficient reproducibility [10,11,12,13]. Thus, traditional approaches are ineffective for isolating high-purity compounds. Recent studies have highlighted high-speed counter-current chromatography as an innovative method for differentiating standard compounds from natural products [14,15,16]. Nevertheless, this approach continues to be hindered by insufficient separation resolution, the requirement for estimating the partition coefficient, and its capability to isolate only moderately polar compounds. Therefore, to achieve further advances in the therapeutic potential of D. superbus, it is crucial to find an alternative approach for the extraction and synthesis of high-purity compounds from this complex natural product.
The study of the modernization of Chinese medicine has led to a major focus on the separation of complex systems, which has emerged as a challenging and prominent area of study within the field of analytical chemistry. Reversed-phase liquid chromatography (RPLC) can solve a wide range of analytical applications but has little or no retention for hydrophilic and polar compounds. The investigation of D. superbus has been previously explored, in which a maltol glycoside was extracted and its anti-inflammatory efficacy was evaluated [17]. This study will continue to carry out the next step of research on D. superbus. Hydrophilic interaction liquid chromatography (HILIC) columns exhibit the opposite elution order as compared to RPLC. The substances that are challenging or non-retentive on RPLC columns exhibit strong retention on HILIC columns under normal experimental conditions. Therefore, the 2D chromatography technique of RPLC and HILIC coupling can complete the analysis of strong and weak polar substances and substantially enhance the efficiency of the analysis [18,19,20]. This study builds upon previous studies by focusing on the continued isolation of subfractions Fr41. The hypoglycemic activity of C-glycosylflavones derived from D. superbus was assessed in vitro using RPLC/RPLC and RPLC/HILIC modes.
The theoretical impact of C-glycosylflavones on AKT and AMPK was examined via molecular docking. To examine the impact of C-glycosylflavones derived from D. superbus on the regulation of insulin resistance in vitro, flow cytometry was performed to measure the uptake of 2-NBDG by cells, and Western blot was performed to monitor the levels of AMPK, AKT, and phosphorylated protein. This quick and efficient extraction method aids in the isolation and purification of D. superbus, as well as expanding its therapeutic activity by offering experimental and theoretical directions for the identification of lead compounds to address glucose metabolic disorders.

2. Results and Discussion

2.1. Separation of Fr41

The findings from the previous study indicated that the separation of D. superbus by medium-pressure preparative chromatography (Hanbon Science and Technology, Huai’an, China) yielded six subfractions, of which Fr41 yielded a final mass of 5.0 g (Figure 1A). Therefore, Fr41 was further separated based on the existing results. The analytical chromatogram for 1D analysis on a 7-X10 column (4.6 × 250 mm, 7 μm) is depicted in Figure 1(Ba). Following linear amplification, a 7-X10 preparation column (20 × 250 mm, 7 µm) was used for 1D separation. The preparation chromatogram is illustrated in Figure 1(Bb). These fractions were obtained and dried following five chromatographic cycles to extract Fr411 (2.1 g) and Fr412 (0.6 g).
A comparative analysis of Fr41 and Fr411 revealed that Fr411 was ineffectively separated on a 7-X10 column and Click XION column (Figure 2(Ab,Bb)). It is mentioned that practical analysis frequently uses RPLC/RPLC chromatography due to its appropriate mobile phase and high potential for each dimension peak [21,22]. By the experimental procedure mentioned in Section 2.2 (Figure 3A), a SunFire® C18 column (analytical and preparative columns, Waters Corporation, Milford, CT, USA) was used to separate Fr411 (80 mg). The separated Fr4111 (28.62 mg) was obtained through the collection and drying of the fraction after five complete cycles of 1D separation.
A comparative analysis of Fr41 and Fr412 revealed that Fr412 was successfully separated on the Click XION column (Figure 2(Bc)) but was not able to be isolated on the 7-X10 column (Figure 2(Ac)). Consequently, the 2D RPLC/HILIC technique was implemented to separate the compounds with high purity [23,24,25]. As for Fr412, the analytical chromatogram on a Click XION analytical column with the above mentioned dimensions is shown in Figure 3(Ba), and the preparative chromatogram on a Click XION preparative column with respective dimensions is illustrated in Figure 3(Bb). Collecting the concentrated dried fraction after the completion of the 2D RPLC/HILIC experiments yielded fraction Fr4121 (49.92 mg). This further demonstrates that the selectivity and peak capacity of chromatographic separation can be enhanced via orthogonal purification.

2.2. Verification of the Purity and the Structural Identification of Fr4111 and Fr4121

The purity of Fr4111 and Fr4121 was assessed by using two columns: a SunFire® C18 column and a Click XION column with the same dimensions: 4.6 × 250 mm, 5 μm. As illustrated in Figure 4A, the chromatograms for both Fr4111 and Fr421 demonstrated that their purity was ≥95%. By comparing the acquired 1H NMR (Bruker Avance NMR spectrometer, Ettlingen, Germany), MS (Agilent Instruments Co., Santa Clara, CA, USA), UV (Shimadzu UV2401PC instrument, Kyoto, Japan), IR (Bruker, Ettlingen, Germany), and 13C NMR (Bruker Avance NMR spectrometer) spectra with those of previous examinations, it was determined that Fr4111 corresponds to 2″-O-rhamnosyllutonarin and Fr4121 to 6‴-O-rhamnosyllutonarin. Figure 4B depicts the chemical structure of the investigated compound. Table 1 describes the 1H-NMR and 13C-NMR information of the studied compounds.
The subsequent experiments were conducted using these two compounds as targets; however, 2″-O-rhamnosyllutonarin (Fr4111), (novel compound) is an isomer of 6‴-O-rhamnosyllutonarin (Fr4121).

2.3. Molecular Docking of 2″-O-rhamnosyllutonarin and 6‴-O-rhamnosyllutonarin

Regulation of metabolic disorders is dependent on AMPK and Akt signaling. The PI3K/Akt pathway serves as the primary mechanism by which insulin induces hypoglycemia, whereas the AMPK pathway mainly regulates glucose uptake in insulin-resistant states and is implicated in cellular differentiation, propagation, and growth [28,29,30].
Accordingly, potential interactions between AKT, AMPK, and 2″-O-rhamnosyllutonarin (Fr4111), 6‴-O-rhamnosyllutonarin (Fr4121), and the positive drug metformin were evaluated using molecular docking. In this analysis, considering AKT, Metformin was identified in a pocket containing abundant amino acids (GLU234, GLU278, THR291, ASP292), while 2″-O-rhamnosyllutonarin (Fr4111) was found in a pocket enclosed by abundant amino acids (LYS158, VAL164, ALA177, GLU228, ALA230, GLU234, MET281, ASP292) and 6‴-O-rhamnosyllutonarin (Fr4121) was found in a pocket enclosed by abundant amino acids (LYS158, PHE161, GLY162, VAL164, ALA177, THR211, MET227, GLU228, GLU234, GLU278, ASN279, MET281, THR291, ASP292) (Figure 5A). Binding energy values for Metformin, 2″-O-rhamnosyllutonarin (Fr4111), and 6‴-O-rhamnosyllutonarin (Fr4121) were −7.11 Kcal/mol, −5.41 Kcal/mol, and −5.65 Kcal/mol, respectively (Table 2). Metformin was identified within an AMPK compartment along with multiple amino acids (ARG83, THR85, ASP136, ER138), while 2″-O-rhamnosyllutonarin (Fr4111) was found in a pocket enclosed by multiple amino acids (ARG10, LYS12, ILE13, GLY14, ARG78, PRO79, SER84, PHE160) and 6‴-O-rhamnosyllutonarin (Fr4121) was found in a pocket enclosed by abundant amino acids (GLN50, VAL81, SER87, GLU139, PRO140, ILE152, ILE153, GLN154, ASP169) (Figure 5B). The values of binding energy for rofecoxib and tunicoside B were −5.90 Kcal/mol, −5.77 Kcal/mol, and −5.68 Kcal/mol, respectively. The findings of these analyses indicated that the minimum estimated binding energy for 2″-O-rhamnosyllutonarin and 6‴-O-rhamnosyllutonarin was comparable to that of Metformin, indicating favorable docking activity.

2.4. 2″-O-rhamnosyllutonarin and 6‴-O-rhamnosyllutonarin Can Enhance Glucose Uptake in IR-HepG2 Cells

Studies on IR are usually performed in insulin-induced insulin-resistant cells [31,32]. On the HepG2 cells, the IR model was efficiently developed in the current study. After 24 h of treatment with defined Fr4111 and Fr421 concentrations, the MTT assay did not detect any change in the HepG2 cell viability (Figure 6A). Insulin resistance, represented primarily by impaired glucose uptake, is the primary feature of T2DM. A major contributor to insulin resistance is obesity [33]. The fluorescent probe 2-NBDG is a fluorescent analog of 2-deoxyglucose, which can specifically bind intracellular glucose and has high sensitivity in detection. It has been widely used to explore cell metabolic functions. The glucose analog 2-NBDG was used to identify the glucose uptake capacity of IR-HepG2 cells. Generally, the fluorescence intensity of 2-NBDG in insulin-resistant cells or bodies is extremely weak, which is at the background value, indicating that cells or bodies have a weak ability to uptake glucose [34,35]. IR substantially reduces the cellular absorption of 2-NBDG, as illustrated in Figure 6B. A classical drug for the clinical treatment of T2DM, metformin (Met), increased insulin-stimulated glucose uptake in HepG2 cells by a substantial concentration of 1 mM. Additionally, glucose uptake by cells was enhanced in the treatment group treated with 2″-O-rhamnosyllutonarin (Fr4111) and 6‴-O-rhamnosyllutonarin (Fr4121) as opposed to the IR group.

2.5. P-AKT and P-AMPK Levels of 2″-O-rhamnosyllutonarin and 6‴-O-rhamnosyllutonarin

Western blot analysis exhibited levels of AKT, phosphorylated-AKT Ser473, AMPK, and phosphorylated-AMPK Thr172. This analysis provided details about the mechanisms by which 2″-O-rhamnosyllutonarin and 6″-O-rhamnosyllutonarin enhance glucose uptake in IR-HepG2 cells. Cell proliferation, growth, and metabolism are all significantly influenced by the PI3K/Akt pathway. This pathway is controlled by several mediators, including insulin-like growth factor (IGF) and epidermal growth factor (EGF), as well as the essential negative regulation of PTEN and other molecular pairs to maintain cell and life homeostasis. The PI3K/Akt signaling pathway represents the predominant downstream molecular pathway associated with insulin. An increase in the phosphorylation level of AKT2 is commonly attributed to the metabolic function of insulin. Specifically, when the body or cells enter the IR state, the phosphorylation level of AKT decreases [36,37,38]. Insulin stimulates AKT2, which is widely regarded as performing its most vital function.
An essential protein kinase, AMPK is crucial for the regulation of energy and metabolism. Important functions of activated AMPK include regulating gene transcription, increasing fatty acid oxidation, and enhancing insulin sensitivity and glucose uptake by skeletal muscle. This AMPK may serve as an innovative pharmacological therapeutic target for obesity, insulin resistance, and T2DM due to its capacity to regulate glucose and fatty acid metabolism [39,40,41].
Data presented in Figure 6C,D represent the effects of 2″-O-rhamnosyllutonarin and 6‴-O-rhamnosyllutonarin on the AKT and AMPK stimulation. The findings reveal that normal HepG2 cells did not exhibit activation of AKT and AMPK, resulting in a relatively low level of protein expression. In contrast to the control group, the phosphorylated protein expression of AKT was remarkably reduced in the IR-HepG2 group when compared to the positive control (Met, 1 mM). This finding confirms that the proposed model has been effectively developed. Moreover, both Fr4111 and Fr4121 can substantially stimulate AKT and AMPK, which also verify the experimental results of molecular docking.

3. Materials and Methods

3.1. Sample Separation and Purity Assay

Based on the previous outcomes, the separation of D. superbus by medium-pressure preparative chromatography yielded six subfractions, of which Fr41 yielded a final mass of 5.0 g. The ID separation was then carried out using a 7-X10 preparative column (analytical and preparative, 20 × 250 mm, 7 μm) (Acchrom Tech, Beijing, China). The mobile phase was chromatography-grade methanol (CH3OH), acetonitrile (ACN) (Yunnan Xinlanjing Chemical Industry, Yuxi, Yunnan, China) (B) and 0.1% of formic acid in H2O (v/v). The chromatogram was acquired at 210 nm after the sample was isocratically eluted at a flow rate of 19 mL/min in 6% B for 90 min. The fraction (Fr41) was divided into Fr411 (0.6 g) and Fr412 (2.1 g) subfractions.
For comparison, Fr41, Fr411, and Fr412 were analyzed via 7-X10 and Click XION analytical columns, respectively. An isocratic elution phase of 0 to 70 min on a 7-X10 column (4.6 × 250 mm, 7 μm) containing 6% CH3OH; a Click XION column (4.6 × 250 mm, 5 μm) exhibiting a linear gradient of 0 to 60 min; and 85 to 80% ACN. At 210 nm, chromatograms were recorded.
Approximately 80 mg of Fr411 was measured to facilitate the next preparation steps. For the 2D separation, a SunFire® column (20 × 250 mm, 5 μm) was selected. The mobile phase and flow rate were the same as in the previous step. The elution conditions were 0–80 min with 20% B isocratic elution. At 210 nm, the chromatogram was acquired, and the target fraction was identified, yielding 28.62 mg of Fr4111.
In the 2D separation step, a Click XION column (20 × 250 mm, 5 μm) was used for Fr412 analysis. Isocratic elution with 90% ACN at a flow rate of 19 mL/min in 90 min (5% v/v trifluoroacetic acid in H2O was another mobile phase) was performed. The target fraction Fr4121 was observed at 210 nm. Following collection and concentration, the final mass was 49.92 mg.
Purity verification of Fr4111 and Fr4121 was performed on SunFire® C18 and Click XION columns (4.6 × 250 mm, 5 µm).
The purity of Fr4111 and Fr4121 was verified via SunFire® C18 and Click XION columns (4.6 × 250 mm, 5 µm). The elution condition on the SunFire® C18 column was a gradient from 20% to 80% CH3OH over 0 to 90 min. The elution requirement on the Click XION column is 0 to 90 min with a gradient of ACN from 90 to 60%. The elution flow rates were set at a constant value of 1 mL/min. Chromatograms were acquired at 210 nm.

3.2. Molecular Docking

Molecular docking is a commonly used drug screening technique that relies on the 3D conformation of target proteins. In this study, the protein IDs corresponding to AKT (6CCY PDB ID) and AMPK (5KQ5 PDB ID) were found in the RCSB PDB database (https://www.rcsb.org/, accessed on 6 May 2023), and the protein IDs were entered from the PDB protein database to examine the 3D structures of the proteins as the macromolecular receptors for molecular docking. The proteins’ small molecule ligands and water molecules were removed via PyMOL 2.5 software. Following hydrogenation, the ligands and receptors were docked through AutoDock 4.2.6 software. Lastly, only those molecular docking outcomes that possessed the least amount of free energy of each docking pair were retained [42,43].

3.3. Cell Culture

Cells (human hepatocellular carcinoma HepG2 cells) were collected from the cell bank of the Shanghai Institute of Biochemistry and Cell Culture (Shanghai, China) and allowed to grow in 10% fetal bovine serum (FBS) (Gibco, Billings, MT, USA) containing Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco, USA) under sterile or standard culture conditions.

3.4. MTT Assay

Cell viability was monitored via MTT assay. After 24 h of HepG2 cell (5 × 103 cells/well) seeding into cultured 96-well plates, they were allowed to grow and treated with defined concentrations (0, 5, 10, 20, 50 μM) of compounds for 24 h. Treated cells were exposed to MTT dye (5 mg/mL, 10 μL/well) and kept in the dark at 37 °C for 4 h. Subsequently, DMSO (100 μL/well) was used to replace the media. The final absorbance (OD) was noted at 490 nm by a microplate reader (Molecular Devices, San Jose, CA, USA).

3.5. 2-NBDG Uptake Assay

Following the modeling procedure, treatments of Fr4111 (10 µM), Fr4121 (10 µM), and Met (1 mM) were added. Next, the medium was replaced with DMEM without glucose. Following a 2 h incubation, 100 μM 2-NBDG was introduced into the medium and maintained for a further 30 min. After PBS washes (thrice), the cells were detached and collected in the dark. The FACS AriaTM flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA) was used to quantify the fluorescence (485/20 and 540/20 nm excitation/emission respectively). The average fluorescence signal of 10,000 cells was measured and the data were displayed.

3.6. Western Blot Analysis

Following the cell treatment, cells were rinsed twice with chilled PBS, and total proteins were isolated via lysis buffer (200 μL). The resulting lysates were centrifuged at 14,000× g, 4 °C, for 15 min. The concentration of protein in the supernatant was assessed via the BCA (Beyotime, China) assay. Proteins were transferred to a PVDF membrane following separation by SDS-PAGE. Following 1 h of blocking at 25 °C with 5% skim milk, membranes were kept at 4 °C overnight with antibodies targeting AMPK, p-AKT, AKT, and p-AMPK (Cell Signaling, Shanghai, China) (1:1000). The membrane was exposed to HRP goat anti-rabbit antibody for 2 h at 25 °C. The protein assay was conducted as per the guidelines outlined in the enhanced chemiluminescent (ECL) assay (Beyotime, Shanghai, China) kit. The bands of protein with β-actin (control) were detected via a 5200 Multi-Luminescent Image Analyzer (Tanon Science and Technology, Shanghai, China).

3.7. Statistical Analysis

All presented data exhibited the means ± SD of replicated experiments. Statistical comparisons were noted via one-way ANOVA or Student’s t-test with the SPSS 22.0 software (SPSS, Chicago, IL, USA). A threshold level of the p-value was specified as p ≤ 0.05.

4. Conclusions

This study identified a new subfraction of D. superbus, Fr41. Two C-glycosylflavones, 2″-O-rhamnosyllutonarin (Fr4111) and 6″-O-rhamnosyllutonarin (Fr4121) were extracted from D. superbus via 2D HPLC in RPLC/RPLC and RPLC/HILIC, and 2″-O-rhamnosyllutonarin was identified as a novel compound isomeric of 6‴-O-rhamnosyllutonarin. The results of molecular docking showed that both compounds exhibited good binding energy with AKT and AMPK. Following IR-HepG2 cell model development, both extracted compounds were tested for insulin resistance improvement. They enhanced 2-NBDG uptake, AKT, and AMPK pathways, and reduced IR symptoms. It was the first preliminary study that reported the 2″-O-rhamnosyllutonarin and 6‴-O-rhamnosyllutonarin isolation from D. superbus. Further research is required to elucidate their mechanistic role and discover the precise glucose metabolism of these compounds. Collectively, it is expected that the methods developed in this study on C-glycosylflavones derived from D. superbus will provide a future direction for the separation and pharmacological effects of C-glycosylflavones.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules29020339/s1. Figure S1: High resolution mass spectrometry of 2″-O-rhamnosyllutonarin; Figure S2: 1H NMR Spectrum (600 MHz) of 2″-O-rhamnosyllutonarin (in MeOH-d4); Figure S3: 13C NMR Spectrum (151 MHz) of 2″-O-rhamnosyllutonarin (in MeOH-d4); Figure S4: The HSQC of 2″-O-rhamnosyllutonarin; Figure S5: The HMBC of 2″-O-rhamnosyllutonarin; Figure S6: The HHCOSY of 2″-O-rhamnosyllutonarin; Figure S7: Ultraviolet (UV) spectra of 2″-O-rhamnosyllutonarin; Figure S8: IR spectra of 2″-O-rhamnosyllutonarin; Figure S9: ESI mass spectrum of 6‴-O-Rhamnosyllutonarin; Figure S10: 1H NMR Spectrum (600 MHz) of 6‴-O-Rhamnosyllutonarin (in MeOH-d4); Figure S11: 13C NMR Spectrum (151 MHz) of 6‴-O-Rhamnosyllutonarin (in MeOH-d4); Figure S12: Ultraviolet (UV) spectra of 6‴-O-Rhamnosyllutonarin; Figure S13: IR spectra of 6‴-O-Rhamnosyllutonarin.

Author Contributions

Conceptualization, methodology, J.D., Z.L., X.Z. and C.Y.; writing—original draft, Z.L., X.Z. and C.Y.; writing—review and editing, Z.L. and Z.W.; formal analysis, X.Z.; investigation, X.Z. and H.Z.; data curation, C.Y. and Y.F.; visualization, Y.F. and Z.W.; supervision, project administration and funding acquisition J.D. and G.L. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Innovation Platform for the Development and Construction of Special Projects of Qinghai Province (2021-ZJ-T05).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in article and Supplementary Material.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kotwas, A.; Karakiewicz, B.; Zabielska, P.; Wieder-Huszla, S.; Jurczak, A. Epidemiological factors for type 2 diabetes mellitus: Evidence from the Global Burden of Disease. Arch. Public Health 2021, 79, 110. [Google Scholar] [CrossRef] [PubMed]
  2. Zick, C.D.; Curtis, D.S.; Meeks, H.; Smith, K.R.; Brown, B.B.; Kole, K.; Kowaleski-Jones, L. The changing food environment and neighborhood prevalence of type 2 diabetes. SSM Popul. Health 2023, 21, 101338. [Google Scholar] [CrossRef] [PubMed]
  3. Sun, H.; Saeedi, P.; Karuranga, S.; Pinkepank, M.; Ogurtsova, K.; Duncan, B.B.; Stein, C.; Basit, A.; Chan, J.C.N.; Mbanya, J.C.; et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022, 183, 101338. [Google Scholar] [CrossRef] [PubMed]
  4. Astudillo, M.; Tosur, M.; Castillo, B.; Rafaey, A.; Siller, A.F.; Nieto, J.; Sisley, S.; McKay, S.; Nella, A.A.; Balasubramanyam, A.; et al. Type 2 diabetes in prepubertal children. Pediatr. Diabetes 2021, 22, 946–950. [Google Scholar] [CrossRef] [PubMed]
  5. Reed, J.; Bain, S.; Kanamarlapudi, V. A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives. Diabetes Metab. Syndr. Obes. 2021, 14, 3567–3602. [Google Scholar] [CrossRef]
  6. Padhi, S.; Dash, M.; Behera, A. Nanophytochemicals for the treatment of type II diabetes mellitus: A review. Environ. Chem. Lett. 2021, 19, 4349–4373. [Google Scholar] [CrossRef]
  7. Zhu, J.; Han, J.; Liu, L.; Liu, Y.; Xu, W.; Li, X.; Yang, L.; Gu, Y.; Tang, W.; Shi, Y.; et al. Clinical expert consensus on the assessment and protection of pancreatic islet β-cell function in type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 2023, 197, 110568. [Google Scholar] [CrossRef]
  8. Yoon, J.J.; Park, J.H.; Kim, H.J.; Jin, H.G.; Kim, H.Y.; Ahn, Y.M.; Kim, Y.C.; Lee, H.S.; Lee, Y.J.; Kang, D.G. Dianthus superbus Improves Glomerular Fibrosis and Renal Dysfunction in Diabetic Nephropathy Model. Nutrients 2019, 11, 553. [Google Scholar] [CrossRef]
  9. Kim, D.H.; Park, G.S.; Nile, A.S.; Kwon, Y.D.; Enkhtaivan, G.; Nile, S.H. Utilization of Dianthus superbus L and its bioactive compounds for antioxidant, anti-influenza, and toxicological effects. Food Chem. Toxicol. 2019, 125, 313–321. [Google Scholar] [CrossRef]
  10. Sun, J.; Yu, J.H.; Song, J.L.; Jiang, C.S.; Tao, Y.; Zhang, H. Two new quinolone alkaloids from Dianthus superbus var. superbus. Tetrahedron Lett. 2019, 60, 161–163. [Google Scholar] [CrossRef]
  11. Ren, Y.N.; Xu, X.B.; Zhang, Q.L.; Lu, Y.Z.; Li, X.M.; Zhang, L.; Tian, J.K. Isolation, characterization, and in rats plasma pharmacokinetic study of a new triterpenoid saponin from Dianthus superbus. Arch. Pharmacal Res. 2017, 40, 159–167. [Google Scholar] [CrossRef] [PubMed]
  12. Tong, Y.; Luo, J.G.; Wang, R.; Wang, X.B.; Kong, L.Y. New cyclic peptides with osteoblastic proliferative activity from Dianthus superbus. Bioorganic Med. Chem. Lett. 2012, 22, 1908–1911. [Google Scholar] [CrossRef] [PubMed]
  13. Hou, X.L.; Gao, Y.Q.; Yang, J.H.; Liu, H.W.; Bai, M.M.; Wu, Z.H.; Li, C.H.; Tian, J.M.; Gao, J.M. Phytoecdysteroids from Dianthus superbus L.: Structures and anti-neuroinflammatory evaluation. Phytochemistry 2023, 212, 113710. [Google Scholar] [CrossRef] [PubMed]
  14. Zuo, G.; Je, K.H.; Guillen Quispe, Y.N.; Shin, K.O.; Kim, H.Y.; Kim, K.H.; Arce, P.H.G.; Lim, S.S. Separation and Identification of Antioxidants and Aldose Reductase Inhibitors in Lepechinia meyenii (Walp.) Epling. Plants 2021, 10, 2773. [Google Scholar] [CrossRef] [PubMed]
  15. Zou, D.; Cui, Y.; Li, S.; Sang, D.; Liu, W.; Zhao, T.; Gu, X.; Chen, T.; Li, Y. The applicability of high-speed counter-current chromatography for preparative separation of biosynthesis products: Glycosylation products as example. J. Sep. Sci. 2021, 44, 4368–4375. [Google Scholar] [CrossRef] [PubMed]
  16. Zhu, Y.; Liu, Y.; Zhan, Y.; Liu, L.; Xu, Y.; Xu, T.; Liu, T. Preparative isolation and purification of five flavonoid glycosides and one benzophenone galloyl glycoside from Psidium guajava by high-speed counter-current chromatography (HSCCC). Molecules 2013, 18, 15648–15661. [Google Scholar] [CrossRef]
  17. Yuan, C.; Dang, J.; Han, Y.; Liu, C.; Yu, S.; Lv, Y.; Cui, Y.B.; Wang, Z.H.; Li, G. Preparative isolation of maltol glycoside from Dianthus superbus and its anti-inflammatory activity in vitro. RSC Adv. 2022, 12, 5031–5041. [Google Scholar] [CrossRef]
  18. Ma, L.J.; Cao, J.L.; Meng, F.C.; Wang, S.P.; Deng, Y.; Wang, Y.T.; Li, P.; Wan, J.B. Quantitative Characterization of Ginsenoside Biotransformation in Panax notoginseng Inflorescences and Leaves by Online Two-Dimensional Liquid Chromatography Coupled to Mass Spectrometry. J. Agric. Food Chem. 2020, 68, 5327–5338. [Google Scholar] [CrossRef]
  19. Chen, Y.Z.; Wu, Y.J.; Liu, X.M.; Li, B.W.; Hu, D.P.; Huang, S.; Ma, M.; Chen, B. Pulsed elution modulation for online comprehensive two-dimensional liquid chromatography coupling reversed-phase liquid chromatography and hydrophilic interaction chromatography. J. Chromatogr. A 2019, 1583, 98–107. [Google Scholar] [CrossRef]
  20. Dang, J.; Zhang, L.; Wang, Q.L.; Mei, L.J.; Yue, H.L.; Liu, Z.G.; Shao, Y.; Gao, Q.B.; Tao, Y.D. Target separation of flavonoids from Saxifraga tangutica using two-dimensional hydrophilic interaction chromatography/reversed-phase liquid chromatography. J. Sep. Sci. 2019, 41, 4419–4429. [Google Scholar] [CrossRef]
  21. Wang, Q.; Chen, W.J.; Wang, Q.L.; Tao, Y.D.; Yu, R.T.; Pan, G.Q.; Dang, J. Preparative separation of isoquinoline alkaloids from Corydalis impatiens using middle chromatogram isolated gel column coupled with positively charged reversed-phase liquid chromatography. J. Sep. Sci. 2020, 43, 2521–2528. [Google Scholar] [CrossRef]
  22. Wang, W.D.; Tao, Y.D.; Jiao, L.J.; Fan, M.X.; Shao, Y.; Wang, Q.L.; Mei, L.J.; Dang, J. Efficient separation of high-purity compounds from Oxytropis falcata using two-dimensional preparative chromatography. J. Sep. Sci. 2017, 40, 3593–3601. [Google Scholar] [CrossRef] [PubMed]
  23. Yu, W.Y.; Jin, H.L.; Shen, A.J.; Deng, L.; Shi, J.L.; Xue, X.Y.; Guo, Y.D.; Liu, Y.F.; Liang, X.M. Purification of high-purity glycyrrhizin from licorice using hydrophilic interaction solid phase extraction coupled with preparative reversed-phase liquid chromatography. J. Chromatogr. B 2017, 1040, 47–52. [Google Scholar] [CrossRef] [PubMed]
  24. Yoshii, T.; Sakama, A.; Kanamori, K.; Nakanishi, K.; Imai, H.; Citterio, D.; Hiruta, Y. Fabrication process development and basic evaluation of eggshell-based column packing material for reversed-phase preparative separation. J. Chromatogr. A 2023, 1688, 463722. [Google Scholar] [CrossRef] [PubMed]
  25. Jiao, L.J.; Tao, Y.D.; Wang, W.D.; Shao, Y.; Mei, L.J.; Wang, Q.L.; Dang, J. Preparative isolation of flavonoid glycosides from Sphaerophysa salsula using hydrophilic interaction solid-phase extraction coupled with two-dimensional preparative liquid chromatography. J. Sep. Sci. 2017, 40, 3808–3816. [Google Scholar] [CrossRef]
  26. Camargo, L.M.D.; Ferezou, J.P.; Tinoco, L.W.; Kaiser, C.R.; Costa, S.S. Flavonoids from Mimosa xanthocentra (Leguminosae: Mimosoideae) and molecular modeling studies for isovitexin-2″-O-alpha-L-rhamnopyranoside rotamers. Phytochem. Lett. 2012, 5, 427–431. [Google Scholar] [CrossRef]
  27. Obmann, A.; Werner, I.; Presser, A.; Zehl, M.; Swoboda, Z.; Purevsuren, S.; Narantuya, S.; Kletter, C.; Glasl, S. Flavonoid C- and O-glycosides from the Mongolian medicinal plant Dianthus versicolor Fisch. Carbohyd. Res. 2012, 346, 1868–1875. [Google Scholar] [CrossRef]
  28. Chen, W.W.; Kang, K.; Lv, J.; Yue, L.; Zhang, W.Q. Galactose-NlGr11 inhibits AMPK phosphorylation by activating the PI3K-AKT-PKF-ATP signaling cascade via insulin receptor and G beta gamma. Insect Sci. 2020, 28, 735–745. [Google Scholar] [CrossRef]
  29. Cui, X.B.; Wang, C.; Li, L.; Fan, D.; Zhou, Y.; Wu, D.; Cui, Q.H.; Fu, F.Y.; Wu, L.L. Insulin decreases myocardial adiponectin receptor 1 expression via PI3K/Akt and FoxO1 pathway. Cardiovasc. Res. 2012, 93, 69–78. [Google Scholar] [CrossRef]
  30. Brandt, N.; De Bock, K.; Richter, E.A.; Hespel, P. Cafeteria diet-induced insulin resistance is not associated with decreased insulin signaling or AMPK activity and is alleviated by physical training in rats. Am. J. Physiol. Endocrinol. Metab. 2010, 299, E215–E224. [Google Scholar] [CrossRef]
  31. Mao, Z.J.; Lin, M.; Zhang, X.; Qin, L.P. Combined Use of Astragalus Polysaccharide and Berberine Attenuates Insulin Resistance in IR-HepG2 Cells via Regulation of the Gluconeogenesis Signaling Pathway. Front. Pharmacol. 2020, 10, 1508. [Google Scholar] [CrossRef] [PubMed]
  32. Li, J.W.; Luo, J.Y.; Chai, Y.Y.; Guo, Y.; Yang, T.Z.; Bao, Y.H. Hypoglycemic effect of Taraxacum officinale root extract and its synergism with Radix Astragali extract. Food Sci. Nutr. 2021, 9, 2075–2085. [Google Scholar] [CrossRef] [PubMed]
  33. Issac, P.K.; Guru, A.; Chandrakumar, S.S.; Lite, C.; Saraswathi, N.T.; Arasu, M.V.; Al-Dhabi, N.A.; Arshad, A.; Arockiaraj, J. Molecular process of glucose uptake and glycogen storage due to hamamelitannin via insulin signaling cascade in glucose metabolism. Mol. Biol. Rep. 2020, 47, 6727–6740. [Google Scholar] [CrossRef] [PubMed]
  34. Erukainure, O.L.; Oyebode, O.A.; Ibeji, C.U.; Koorbanally, N.A.; Islam, M.S. Vernonia Amygdalina Del. stimulated glucose uptake in brain tissues enhances antioxidative activities; and modulates functional chemistry and dysregulated metabolic pathways. Metab. Brain Dis. 2019, 34, 721–732. [Google Scholar] [CrossRef] [PubMed]
  35. Ramirez, E.; Picatoste, B.; Gonzalez-Bris, A.; Oteo, M.; Cruz, F.; Caro-Vadillo, A.; Egido, J.; Tunon, J.; Morcillo, M.A.; Lorenzo, O. Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: Role of GLP-1 isoforms in Glut4 receptor trafficking. Cardiovasc. Diabetol. 2018, 17, 12. [Google Scholar] [CrossRef]
  36. Dai, H.B.; Wang, H.Y.; Wang, F.Z.; Qian, P.; Gao, Q.; Zhou, H.; Zhou, Y.B. Adrenomedullin ameliorates palmitic acid-induced insulin resistance through PI3K/Akt pathway in adipocytes. Acta Diabetol. 2022, 59, 661–673. [Google Scholar] [CrossRef]
  37. Yang, Q.; Wen, Y.M.; Shen, J.; Chen, M.M.; Wen, J.H.; Li, Z.M.; Liang, Y.Z.; Xia, N. Guava Leaf Extract Attenuates Insulin Resistance via the PI3K/Akt Signaling Pathway in a Type 2 Diabetic Mouse Model. Diabetes Metab. Syndr. Obes. 2020, 13, 713–718. [Google Scholar] [CrossRef]
  38. Shu, L.Y.; Zhao, H.; Huang, W.L.; Hou, G.S.; Song, G.Y.; Ma, H.J. Resveratrol Upregulates mmu-miR-363-3p via the PI3K-Akt Pathway to Improve Insulin Resistance Induced by a High-Fat Diet in Mice. Diabetes Metab. Syndr. Obes. 2020, 13, 391–403. [Google Scholar] [CrossRef]
  39. Mazibuko-Mbeje, S.E.; Dludla, P.V.; Roux, C.; Johnson, R.; Ghoor, S.; Joubert, E.; Louw, J.; Opoku, A.R.; Muller, C.J.F. Aspalathin-Enriched Green Rooibos Extract Reduces Hepatic Insulin Resistance by Modulating PI3K/AKT and AMPK Pathways. Int. J. Mol. Sci. 2019, 20, 633. [Google Scholar] [CrossRef]
  40. Lei, Y.Y.; Gong, L.L.; Tan, F.G.; Liu, Y.X.; Li, S.S.; Shen, H.W.; Zhu, M.; Cai, W.W.; Xu, F.; Hou, B.; et al. Vaccarin ameliorates insulin resistance and steatosis by activating the AMPK signaling pathway. Eur. J. Pharmacol. 2019, 851, 13–24. [Google Scholar] [CrossRef]
  41. Rogacka, D.; Audzeyenka, I.; Rychlowski, M.; Rachubik, P.; Szrejder, M.; Angielski, S.; Piwkowska, A. Metformin overcomes high glucose-induced insulin resistance of podocytes by pleiotropic effects on SIRT1 and AMPK. BBA Mol. Basis Dis. 2018, 1864, 115–125. [Google Scholar] [CrossRef] [PubMed]
  42. Haroon, M.; Khalid, M.; Shahzadi, K.; Akhtar, T.; Saba, S.; Rafique, J.; Ali, S.; Irfan, M.; Alam, M.M.; Imran, M. Alkyl 2-(2-(arylidene)alkylhydrazinyl)thiazole-4-carboxylates: Synthesis, acetyl cholinesterase inhibition and docking studies. J. Mol. Struct. 2021, 1245, 131063. [Google Scholar] [CrossRef]
  43. Khan, M.S.; Khalid, M.; Ahmad, M.S.; Ahmad, M.; Ashafaq, M.; Rahisuddin; Arif, R.; Shahid, M. Synthesis, spectral and crystallographic study, DNA binding and molecular docking studies of homo dinuclear Co(II) and Ni(II) complexes. J. Mol. Struct. 2019, 1175, 889–899. [Google Scholar] [CrossRef]
Molecules 29 00339 g001
Figure 1. A fraction of D. superbus-derived Fr41 was separated by Fr4 pretreatment chromatograms and 1D RPLC. A Spherical C18 preparative column was used to generate Fr4 (A). The following settings were applied to a 7-X10 analytical column (4.6 × 250 mm, 7 μm) to analyze Fr41; mobile phase A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: CH3OH, gradient: 0 to 90 min, 6% B, a chromatogram at 210 nm was noted (Ba). A 7-X10 preparative column with defined dimensions was used to achieve 1D separation of Fr41. The column was designed as follows: A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: CH3OH, gradient: 0 to 90 min 6% B, a chromatogram was noted at 210 nm (Bb).
Figure 1. A fraction of D. superbus-derived Fr41 was separated by Fr4 pretreatment chromatograms and 1D RPLC. A Spherical C18 preparative column was used to generate Fr4 (A). The following settings were applied to a 7-X10 analytical column (4.6 × 250 mm, 7 μm) to analyze Fr41; mobile phase A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: CH3OH, gradient: 0 to 90 min, 6% B, a chromatogram at 210 nm was noted (Ba). A 7-X10 preparative column with defined dimensions was used to achieve 1D separation of Fr41. The column was designed as follows: A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: CH3OH, gradient: 0 to 90 min 6% B, a chromatogram was noted at 210 nm (Bb).
Molecules 29 00339 g001
Molecules 29 00339 g002
Figure 2. Comparative chromatographic profiles of Fr41, Fr411, Fr412. Fr41, Fr411, and Fr412 were examined via a 7-X10 analytical column with respective dimensions. The column was adjusted as follows: mobile phase A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: CH3OH; gradient: 0 to 70 min, 6% B (A). To evaluate Fr41, Fr411, and Fr412, a Click XION analytical column with defined dimensions was used with the following respective setups: mobile phase A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: ACN, gradient: 0 to 60 min, 85 to 80% B, a chromatogram at 210 nm was noted (B).
Figure 2. Comparative chromatographic profiles of Fr41, Fr411, Fr412. Fr41, Fr411, and Fr412 were examined via a 7-X10 analytical column with respective dimensions. The column was adjusted as follows: mobile phase A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: CH3OH; gradient: 0 to 70 min, 6% B (A). To evaluate Fr41, Fr411, and Fr412, a Click XION analytical column with defined dimensions was used with the following respective setups: mobile phase A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: ACN, gradient: 0 to 60 min, 85 to 80% B, a chromatogram at 210 nm was noted (B).
Molecules 29 00339 g002
Molecules 29 00339 g003
Figure 3. In RPLC/HILIC and 2D RPLC/RPLC modes, Fr411 and Fr412 were separated. Fr411 was observed with a SunFire® C18 analytical column (4.6 × 250 mm, 7 μm) with the following respective parameters: mobile phase A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: CH3OH, gradient: 0 to 80 min, 20% B, a chromatogram was noted at 210 nm (Aa). For 2D separation, a SunFire® C18 preparative column (20 × 250 mm, 5 μm) was used with these subsequent setups: mobile phase A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: CH3OH, gradient: 0 to 80 min, 20% B, a chromatogram was noted at 210 nm (Ab). The Click XION analytical column (4.6 × 250 mm, 7 μm) was used to examine Fr412. The column was set up as follows: mobile phase A: chromatographic grade H2O containing 5% trifluoroacetic acid v/v, B: ACN, gradient: 0 to 80 min, 90% B, a chromatogram was noted at 210 nm (Ba). For 2D separation, a Click XION preparative column with defined dimensions was used with the respective arrangements: mobile phase A: chromatographic grade H2O containing 5% trifluoroacetic acid v/v, B: ACN, gradient: 0 to 80 min, 90% B, a chromatogram was noted at 210 nm (Bb).
Figure 3. In RPLC/HILIC and 2D RPLC/RPLC modes, Fr411 and Fr412 were separated. Fr411 was observed with a SunFire® C18 analytical column (4.6 × 250 mm, 7 μm) with the following respective parameters: mobile phase A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: CH3OH, gradient: 0 to 80 min, 20% B, a chromatogram was noted at 210 nm (Aa). For 2D separation, a SunFire® C18 preparative column (20 × 250 mm, 5 μm) was used with these subsequent setups: mobile phase A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: CH3OH, gradient: 0 to 80 min, 20% B, a chromatogram was noted at 210 nm (Ab). The Click XION analytical column (4.6 × 250 mm, 7 μm) was used to examine Fr412. The column was set up as follows: mobile phase A: chromatographic grade H2O containing 5% trifluoroacetic acid v/v, B: ACN, gradient: 0 to 80 min, 90% B, a chromatogram was noted at 210 nm (Ba). For 2D separation, a Click XION preparative column with defined dimensions was used with the respective arrangements: mobile phase A: chromatographic grade H2O containing 5% trifluoroacetic acid v/v, B: ACN, gradient: 0 to 80 min, 90% B, a chromatogram was noted at 210 nm (Bb).
Molecules 29 00339 g003
Molecules 29 00339 g004
Figure 4. Analysis of the chemical structures and purity of Fr4111 and Fr4121. A SunFire® C18 column with defined dimensions was used to evaluate Fr4111 and Fr4121 at the subsequent parameters: mobile phase A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: CH3OH; gradient: 0 to 90 min, 20 to 80% B (Aa,Ac), and with a Click XION column, with the following respective setup: mobile phase A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: ACN; gradient: 0 to 90 min, 90 to 60% B (Ab,Ad). The chemical structure of the Fr4111 and Fr4121 compounds, extracted from D. superbus (B).
Figure 4. Analysis of the chemical structures and purity of Fr4111 and Fr4121. A SunFire® C18 column with defined dimensions was used to evaluate Fr4111 and Fr4121 at the subsequent parameters: mobile phase A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: CH3OH; gradient: 0 to 90 min, 20 to 80% B (Aa,Ac), and with a Click XION column, with the following respective setup: mobile phase A: 0.1% of formic acid in chromatographic grade H2O (v/v), B: ACN; gradient: 0 to 90 min, 90 to 60% B (Ab,Ad). The chemical structure of the Fr4111 and Fr4121 compounds, extracted from D. superbus (B).
Molecules 29 00339 g004
Molecules 29 00339 g005
Figure 5. Analysis of the AKT’s interaction with 2″-O-rhamnosyllutonarin (Fr4111), 6‴-O-rhamnosyllutonarin (Fr4121), and Metformin via molecular docking (A). Molecular docking analysis of AMPK binding to 2″-O-rhamnosyllutonarin (Fr4111), 6‴-O-rhamnosyllutonarin (Fr4121), and Metformin (B). Metformin, 2″-O-rhamnosyllutonarin (Fr4111), and 6‴-O-rhamnosyllutonarin (Fr4121) structures are shown in green.
Figure 5. Analysis of the AKT’s interaction with 2″-O-rhamnosyllutonarin (Fr4111), 6‴-O-rhamnosyllutonarin (Fr4121), and Metformin via molecular docking (A). Molecular docking analysis of AMPK binding to 2″-O-rhamnosyllutonarin (Fr4111), 6‴-O-rhamnosyllutonarin (Fr4121), and Metformin (B). Metformin, 2″-O-rhamnosyllutonarin (Fr4111), and 6‴-O-rhamnosyllutonarin (Fr4121) structures are shown in green.
Molecules 29 00339 g005
Molecules 29 00339 g006
Figure 6. The effects of various concentrations of 2″-O-rhamnosyllutonarin (Fr4111) and 6‴-O-rhamnosyllutonarin (Fr4121) on the HepG2 cells were evaluated via the MTT assay (A). The quantification of glucose uptake by IR-HepG2 cells was assessed via flow cytometry analysis using 2-NBDG as a fluorescent probe (B). The p-value, ## p ≤ 0.01 in contrast to control cells, * p ≤ 0.05, and ** p ≤ 0.01 compared to IR-HepG2 cells. At least three independent experiments were conducted to evaluate duplicate samples. Western blot analysis quantified the phosphorylation levels of AMPK and AKT (C,D). The p-value, ## p ≤ 0.01 relative to normal cells, * p ≤ 0.05, and ** p ≤ 0.01 relative to IR-HepG2 cells.
Figure 6. The effects of various concentrations of 2″-O-rhamnosyllutonarin (Fr4111) and 6‴-O-rhamnosyllutonarin (Fr4121) on the HepG2 cells were evaluated via the MTT assay (A). The quantification of glucose uptake by IR-HepG2 cells was assessed via flow cytometry analysis using 2-NBDG as a fluorescent probe (B). The p-value, ## p ≤ 0.01 in contrast to control cells, * p ≤ 0.05, and ** p ≤ 0.01 compared to IR-HepG2 cells. At least three independent experiments were conducted to evaluate duplicate samples. Western blot analysis quantified the phosphorylation levels of AMPK and AKT (C,D). The p-value, ## p ≤ 0.01 relative to normal cells, * p ≤ 0.05, and ** p ≤ 0.01 relative to IR-HepG2 cells.
Molecules 29 00339 g006
Table 1. Information of the isolate from D. superbus.
Table 1. Information of the isolate from D. superbus.
CompoundNameStructureESI−1H-NMR (600 MHz, DMSO-d6)13C-NMR (151 MHz, DMSO-d6)
Fr41112″-O-rhamnosyllutonarinMolecules 29 00339 i001755.4413.59 (1H, s, 5-OH), 7.44 (1H, dd, J = 8.2, 2.0 Hz, H-6′), 7.42 (1H, brs, H-2′), 6.90 (1H, d, J = 8.2 Hz, H-5′), 6.87 (1H, s, H-8), 6.75 (1H, s, H-3), 4.97 (1H, d, J = 7.9 Hz, H-1⁗), 4.95 (1H, brs, H-1‴), 4.71 (1H, d, J = 9.9 Hz, H-1″), 4.13 (1H, dd, J = 9.9, 8.5 Hz, H-2″), 3.61 (1H, brs, H-2‴), 3.58, 3.64 (each 1H, m, H-6″), 3.56, 3.78 (each 1H, m, H-6⁗), 3.50 (1H, m, H-5⁗), 3.37 (1H, m, H-2⁗), 3.36 (1H, m, H-3″), 3.32 (1H, m, H-3⁗), 3.28 (1H, m, H-4″), 3.24 (1H, m, H-4⁗), 3.18 (1H, m, H-5″), 3.15 (1H, dd, J = 9.3, 3.0, H-3‴), 2.88 (1H, dd, J = 9.3, 9.3, H-4‴), 2.32 (1H, dq, J = 9.3, 6.2, H-5‴), 0.59 (3H, d, J = 6.2, H-6‴) [26].181.9 (C-3), 164.3 (C-1), 162.7 (C-6), 159.3 (C-4), 156.6 (C-8), 150.2 (C-4′), 145.9 (C-3′), 121.1 (C-1′), 119.2 (C-6′), 116.0 (C-5′), 113.4 (C-2′), 110.5 (C-5), 105.0 (C-9), 103.1 (C-2), 102.0 (C-1⁗), 100.5 (C-1‴), 94.3 (C-7), 81.1 (C-5″), 78.9 (C-3″), 77.3 (C-5⁗), 76.7 (C-2″), 75.7 (C-3⁗), 73.8 (C-2⁗), 71.6 (C-4″), 71.2 (C-1″), 70.5 (C-2‴), 70.2 (C-3‴), 69.7 (C-4″,4⁗), 68.3 (C-5‴), 60.9 (C-6⁗), 60.3 (C-6″), 17.6 (C-6‴) [26].
Fr41216‴-O-rhamnosyllutonarinMolecules 29 00339 i002755.4213.61 (1H, s, 5-OH), 7.45 (1H, dd, J = 8.4, 2.0 Hz, H-6′), 7.41 (1H, d, H-2′), 6.95 (1H, d, J = 8.4 Hz, H-5′), 6.77 (1H, s, H-3), 6.75 (1H, s, H-8), 4.99 (1H, d, J = 7.1 Hz, H-1‴), 4.65 (1H, d, J = 9.8 Hz, H-1″), 4.63 (1H, brs, H-1⁗), 3.94 (1H, dd, J = 9.8, 8.7 Hz, H-2″), 3.93 (1H, brd, J = 12.0, H-6‴), 3.73 (1H, dd, J = 3.3, 1.4 Hz, H-2⁗), 3.68 (1H, m, H-5‴), 3.55 (1H, dd, J = 9.4, 3.3 Hz, H-3⁗), 3.54–3.65 (2H, m), 3.51 (1H, m, H-6‴), 3.46 (1H, dq, J = 9.3, 6.2 Hz, H-5⁗), 3.34 (1H, m, H-2‴), 3.33 (1H, m, H-3‴), 3.28 (1H, m, H-4″), 3.22 (1H, m, H-3″), 3.20 (1H, m, H-4⁗), 3.19 (1H, m, H-4‴), 3.17 (1H, m, H-5″), 1.13 (3H, d, J = 6.2, H-6⁗) [27].182.0 (C-4), 164.7 (C-2), 162.5 (C-7), 159.5 (C-5), 156.6 (C-9), 150.0 (C-4′), 145.7 (C-3′), 121.2 (C-1′), 119.4 (C-6′), 116.3 (C-5′), 113.5 (C-2′), 110.5 (C-6), 105.0 (C-10), 103.3 (C-3), 101.3 (C-1‴), 100.6 (C-1⁗), 93.5 (C-8), 81.2 (C-5″), 78.9 (C-3″), 75.7 (C-5‴), 75.5 (C-3‴), 73.8 (C-2‴), 72.8 (C-1″), 72.0 (C-4⁗), 70.9 (C-3⁗), 70.8 (C-2″), 70.4 (C-2⁗), 69.6 (C-4″,4‴), 68.4 (C-5⁗), 66.2 (C-6‴), 60.3 (C-6″), 17.9 (C-6⁗) [27].
Table 2. The binding energy of 2″-O-rhamnosyllutonarin (Fr4111), 6‴-O-rhamnosyllutonarin (Fr4121), and Metformin in AKT and AMPK.
Table 2. The binding energy of 2″-O-rhamnosyllutonarin (Fr4111), 6‴-O-rhamnosyllutonarin (Fr4121), and Metformin in AKT and AMPK.
TypeCompoundsRMSDBinding Energy (Kcal/mol)
AKTMetformin33.50−7.11
2″-O-rhamnosyllutonarin34.15−5.41
6‴-O-rhamnosyllutonarin32.63−5.65
AMPKMetformin99.38−5.90
2″-O-rhamnosyllutonarin89.32−5.77
6‴-O-rhamnosyllutonarin85.10−5.68
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lin, Z.; Zhou, X.; Yuan, C.; Fang, Y.; Zhou, H.; Wang, Z.; Dang, J.; Li, G. Impact of Preparative Isolation of C-Glycosylflavones Derived from Dianthus superbus on In Vitro Glucose Metabolism. Molecules 2024, 29, 339. https://doi.org/10.3390/molecules29020339

AMA Style

Lin Z, Zhou X, Yuan C, Fang Y, Zhou H, Wang Z, Dang J, Li G. Impact of Preparative Isolation of C-Glycosylflavones Derived from Dianthus superbus on In Vitro Glucose Metabolism. Molecules. 2024; 29(2):339. https://doi.org/10.3390/molecules29020339

Chicago/Turabian Style

Lin, Zikai, Xiaowei Zhou, Chen Yuan, Yan Fang, Haozheng Zhou, Zhenhua Wang, Jun Dang, and Gang Li. 2024. "Impact of Preparative Isolation of C-Glycosylflavones Derived from Dianthus superbus on In Vitro Glucose Metabolism" Molecules 29, no. 2: 339. https://doi.org/10.3390/molecules29020339

APA Style

Lin, Z., Zhou, X., Yuan, C., Fang, Y., Zhou, H., Wang, Z., Dang, J., & Li, G. (2024). Impact of Preparative Isolation of C-Glycosylflavones Derived from Dianthus superbus on In Vitro Glucose Metabolism. Molecules, 29(2), 339. https://doi.org/10.3390/molecules29020339

Article Metrics

Back to TopTop